Glimepiride (40 mg)

Glimepiride (40 mg)

Daunorubicin 20 mg Injection contains Daunorubicin Hydrochloride (20 mg) and is an anthracycline anticancer medicine used in the treatment of acute leukemias by inhibiting cancer cell DNA replication and growth.

- +

Form: Injection

Manufacturer: Generic Pharmaceuticals

Country of Origin: India

Overview: Daunorubicin 20 mg Injection is a prescription chemotherapy medicine containing Daunorubicin Hydrochloride (20 mg) used primarily in the treatment of acute leukemias including acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). Key Benefits: – Effective in treating acute leukemias – Inhibits cancer cell DNA replication – Used in induction chemotherapy protocols Composition: Daunorubicin Hydrochloride (20 mg) How It Works: Daunorubicin works by intercalating into DNA and inhibiting topoisomerase II, which prevents DNA replication and leads to cancer cell death. Usage Instructions: – Administered only by qualified healthcare professionals – Dosage and schedule depend on treatment protocol and patient condition – Not for self administration Side Effects: – Bone marrow suppression – Nausea, vomiting, hair loss – Cardiotoxicity with long term or high dose use Precautions: – Regular monitoring of heart function and blood counts is required – Increased risk of infection and bleeding – Avoid use during pregnancy and breastfeeding unless clearly advised Storage Instructions: – Store below 25°C, protect from light, do not freeze Manufacturer: Generic Pharmaceuticals Disclaimer: To be sold by retail on the prescription of a registered medical practitioner only.

Composition

Daunorubicin Hydrochloride (20 mg)

Pack Size

1 Vial

Form

Injection

Manufacturer

Generic Pharmaceuticals

Brand

Daunorubicin

Country of Origin

India

Strength

20 mg

Usage Category

Anticancer / Chemotherapy Medicines

Storage Conditions

do not freeze, protect from light, Store below 25°C

Prescription Required

Yes

Administration Route

Injection (Intravenous)

Dosage Form

Injection

Marketed By

Generic Pharmaceuticals

Reviews

There are no reviews yet.

Be the first to review “Glimepiride (40 mg)”

Your email address will not be published. Required fields are marked *

Requirement List
Scroll to Top